Showing results (141-150 of 6,950) with videos related to
Sort By:
Pageof 695
Journal of Clinical Pharmacology|November 1, 2011
Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover studyGeorgina Cirrincione-Dall, Barbara J Brennan, Rosa M Ballester-Sanchis, et al.Journal of Clinical Pharmacology|August 1, 1990
Noninvasive blood pressure monitoring at the finger for studying short lasting pressor responses in manY Christen, B Waeber, J Nussberger, et al.Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of fingolimod phosphate in healthy participantsKai Wu, Francois Mercier, Olivier J David, et al.Journal of Clinical Pharmacology|November 24, 2011
Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucomaLuciano Quaranta, Andreas Katsanos, Irene Floriani, et al.Journal of Clinical Pharmacology|September 30, 2011
Dabigatran etexilate in atrial fibrillation patients with severe renal impairment: dose identification using pharmacokinetic modeling and simulationThorsten Lehr, Sebastian Haertter, Karl-Heinz Liesenfeld, et al.Journal of Clinical Pharmacology|September 30, 2011
Clinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairmentSudharshan Hariharan, Rajanikanth MadabushiJournal of Clinical Pharmacology|September 30, 2011
Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertensionWei-Jie Zeng, Yun-Juan Sun, Qing Gu, et al.Journal of Clinical Pharmacology|September 29, 2011
Tigecycline pharmacokinetics in subjects with various degrees of renal functionJoan M Korth-Bradley, Steven M Troy, Kyle Matschke, et al.Journal of Clinical Pharmacology|December 14, 2011
Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498Pradeep J Nathan, Mark A Bush, Wenli X Tao, et al.Journal of Clinical Pharmacology|December 14, 2011
Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy resultsJohn P Gibbs, Jill Fredrickson, Todd Barbee, et al.Pageof 695